↓ Skip to main content

Selective anti-proliferative activities of Carica papaya leaf juice extracts against prostate cancer

Overview of attention for article published in Biomedicine & Pharmacotherapy, February 2017
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter
1 X user
facebook
1 Facebook page
video
2 YouTube creators

Readers on

mendeley
110 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Selective anti-proliferative activities of Carica papaya leaf juice extracts against prostate cancer
Published in
Biomedicine & Pharmacotherapy, February 2017
DOI 10.1016/j.biopha.2017.02.050
Pubmed ID
Authors
Abstract

Prostate cancer (PCa) is the leading cause of cancer related deaths in men. Carica papaya is a popular tropical plant that has been traditionally used for its nutritional and medicinal properties. We investigated the anti-proliferative responses of papaya leaf juice (LJP) and its various extracts ("biological"- in vitro digested, "physical"- size exclusion, and "chemical"-solvent extraction) on a range of cell lines representing benign hyperplasia, tumorigenic and normal cells of prostate origin. Time course analysis (by 24h, 48h and 72h) of LJP (1-0.1mg/mL) before and after in vitro digestion, and of molecular weight based fractions of LJP showed anti-proliferative responses. The medium polarity fraction of LJP (0.03-0.003mg/mL) after 72h exposure showed potent growth inhibitory (IC50=0.02-0.07mg/mL) and cytotoxic activities on all prostate cells, with the exception of the normal (RWPE-1 and WPMY-1) cells. Flow cytometry analysis showed S phase cell cycle arrest and apoptosis as a possible mechanism for these activities. Medium polar fraction of LJP also inhibited migration and adhesion of metastatic PC-3 cells. This is the first report suggesting selective anti-proliferative and anti-metastatic attributes of LJP extract against prostatic diseases, including PCa.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 110 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 110 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Bachelor 16 15%
Student > Master 12 11%
Lecturer 7 6%
Student > Ph. D. Student 7 6%
Student > Postgraduate 6 5%
Other 10 9%
Unknown 52 47%
Readers by discipline
Readers by discipline Count As %
Agricultural and Biological Sciences 10 9%
Pharmacology, Toxicology and Pharmaceutical Science 9 8%
Biochemistry, Genetics and Molecular Biology 7 6%
Medicine and Dentistry 6 5%
Immunology and Microbiology 4 4%
Other 17 15%
Unknown 57 52%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 December 2023.
All research outputs
#15,742,933
of 25,382,440 outputs
Outputs from Biomedicine & Pharmacotherapy
#2,501
of 6,545 outputs
Outputs of similar age
#183,085
of 325,414 outputs
Outputs of similar age from Biomedicine & Pharmacotherapy
#47
of 124 outputs
Altmetric has tracked 25,382,440 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 6,545 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 325,414 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 124 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.